{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:39Z","timestamp":1791331599578,"version":"4.3.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.biopha.2021.112527","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:47:24Z","timestamp":1639086444000},"page":"112527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines"],"prefix":"10.1016","volume":"146","author":[{"given":"Mohammad Reza","family":"Zinatizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman Kheirandish","family":"Zarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zinatizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112527_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138996","article-title":"Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: a global health emergency","volume":"730","author":"Acter","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biopha.2021.112527_bib2","series-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)","author":"Cascella","year":"2021"},{"issue":"2","key":"10.1016\/j.biopha.2021.112527_bib3","article-title":"Reimagining science and technology education in the COVID-19 portal","volume":"11","author":"Alsop","year":"2020","journal-title":"J. Act. Sci. Technol. Educ."},{"key":"10.1016\/j.biopha.2021.112527_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104327","article-title":"Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status","volume":"83","author":"Abd El-Aziz","year":"2020","journal-title":"Infect., Genet. Evol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112527_bib5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112527_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019\u2013COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"31","key":"10.1016\/j.biopha.2021.112527_bib7","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.3748\/wjg.v26.i31.4579","article-title":"COVID-19 pandemic: pathophysiology and manifestations from the gastrointestinal tract","volume":"26","author":"Galanopoulos","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112527_bib8","first-page":"461","article-title":"Targeting SARS-CoV-2 novel corona (COVID-19) virus infection using medicinal","author":"Adetunji","year":"2021","journal-title":"Plants Med. Plants Lung Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmm.IJMM_20_138","article-title":"Current understanding, knowledge gaps and a perspective on the future of COVID-19 Infections: a systematic review","volume":"38","author":"Chakravarti","year":"2020","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.biopha.2021.112527_bib10","first-page":"275","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020"},{"key":"10.1016\/j.biopha.2021.112527_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104585","article-title":"SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies","volume":"131","author":"Karamitros","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01652176.2020.1766725","article-title":"COVID-19: animals, veterinary and zoonotic links","volume":"40","author":"Tiwari","year":"2020","journal-title":"Vet. Q."},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/22221751.2020.1733440","article-title":"No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2021.112527_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101830","article-title":"SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus","author":"Dhama","year":"2020","journal-title":"Traval Med. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2021.112527_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2471\/BLT.20.253591","article-title":"Variant analysis of SARS-CoV-2 genomes","volume":"98","author":"Koyama","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"15","key":"10.1016\/j.biopha.2021.112527_bib16","doi-asserted-by":"crossref","first-page":"R849","DOI":"10.1016\/j.cub.2020.06.031","article-title":"On the evolutionary epidemiology of SARS-CoV-2","volume":"30","author":"Day","year":"2020","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-70827-z","article-title":"Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide","volume":"10","author":"Isabel","year":"2020","journal-title":"Sci. Rep."},{"issue":"6525","key":"10.1016\/j.biopha.2021.112527_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.abe5901","article-title":"Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans","volume":"371","author":"Munnink","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112527_bib19","first-page":"1","article-title":"SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse","author":"Konings","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2021.112527_bib20","unstructured":"Centers for Disease Control and Prevention. CDC Science Brief: Omicron (B.1.1.529) Variant (Accessed 4 December 2021). Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/scientific-brief-omicron-variant.html."},{"issue":"9","key":"10.1016\/j.biopha.2021.112527_bib21","doi-asserted-by":"crossref","first-page":"2100133","DOI":"10.2807\/1560-7917.ES.2021.26.9.2100133","article-title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y. V1 (B. 1.1. 7, variant of concern 202012\/01) in France, January to March 2021","volume":"26","author":"Gaymard","year":"2021","journal-title":"Eurosurveillance"},{"issue":"10","key":"10.1016\/j.biopha.2021.112527_bib22","doi-asserted-by":"crossref","first-page":"2100131","DOI":"10.2807\/1560-7917.ES.2021.26.10.2100130","article-title":"Tracking SARS-CoV-2 lineage B. 1.1. 7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021","volume":"26","author":"Borges","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.biopha.2021.112527_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.01.049","article-title":"In response to: multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak","author":"Pe\u00f1arrubia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2021.112527_bib24","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/1873-3468.14076","article-title":"Enhanced binding of the N501Y\u2010mutated SARS\u2010CoV\u20102 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations","volume":"595","author":"Luan","year":"2021","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251123","article-title":"The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)","volume":"16","author":"Vousden","year":"2021","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.biopha.2021.112527_bib26","doi-asserted-by":"crossref","first-page":"taab051","DOI":"10.1093\/jtm\/taab051","article-title":"Inactivated COVID-19 vaccine BBV152\/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2","volume":"28","author":"Sapkal","year":"2021","journal-title":"J. Travel Med."},{"key":"10.1016\/j.biopha.2021.112527_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.07.027","article-title":"Tackling COVID-19 with neutralizing monoclonal antibodies","author":"Corti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112527_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.08.014","article-title":"Generation and transmission of inter-lineage recombinants in the SARS-CoV-2 pandemic","author":"Jackson","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2021.112527_bib29","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1538-7836.2006.02095.x","article-title":"Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke","volume":"4","author":"Paciaroni","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.biopha.2021.112527_bib30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2021.2294","article-title":"SARS-CoV-2 variants of concern in the United States\u2014challenges and opportunities","volume":"325","author":"Walensky","year":"2021","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.biopha.2021.112527_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.biopha.2021.112527_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167058","article-title":"Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants","volume":"433","author":"Laffeber","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2021.112527_bib33","article-title":"SARS-CoV-2 variants: a synopsis of in vitro efficacy data of convalescent plasma, currently marketed vaccines, and monoclonal antibodies","author":"Focosi","year":"2021","journal-title":"Multidiscip. Digit. Publ. Inst."},{"key":"10.1016\/j.biopha.2021.112527_bib34","article-title":"Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: their significant mutations in S\u2010glycoprotein","author":"Chakraborty","year":"2021","journal-title":"Infect., Re\u2010Infect. Immune Escape Vaccin. Act. Rev. Med. Virol."},{"key":"10.1016\/j.biopha.2021.112527_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152130","article-title":"Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection","author":"Serpeloni","year":"2021","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.biopha.2021.112527_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.06.005","article-title":"SnapShot: SARS-CoV-2 antibodies","volume":"29","author":"Montefiori","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.biopha.2021.112527_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.biopha.2021.112527_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.46234\/ccdcw2021.109","article-title":"Emerging variants of B. 1.617 lineage identified among returning chinese employees working in india\u2014chongqing municipality, China, April 2021","volume":"3","author":"Ye","year":"2021","journal-title":"China CDC Wkly."},{"key":"10.1016\/j.biopha.2021.112527_bib39","doi-asserted-by":"crossref","unstructured":"Loconsole, D., et al., Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012\/01-lineage B. 1.1. 7 infection in healthcare workers, Italy. Clinical Microbiology and Infection, 2021.","DOI":"10.1016\/j.cmi.2021.05.007"},{"key":"10.1016\/j.biopha.2021.112527_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2021.100287","article-title":"Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil","volume":"13","author":"da Silva","year":"2021","journal-title":"One Health"},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib41","first-page":"1","article-title":"Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants","volume":"4","author":"Wang","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2021.112527_bib42","doi-asserted-by":"crossref","unstructured":"C.K. Leung\u00a0et al., Revealing COVID-19 Data by Data Mining and Visualization. in International Conference on Intelligent Networking and Collaborative Systems 2021 Springer,.","DOI":"10.1007\/978-3-030-84910-8_8"},{"issue":"7","key":"10.1016\/j.biopha.2021.112527_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.biopha.2021.112527_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/pathogens10060633","article-title":"The Emerging Concern and Interest SARS-CoV-2 Variants","volume":"10","author":"Janik","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.biopha.2021.112527_bib45","series-title":"Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)","author":"Aleem","year":"2021"},{"key":"10.1016\/j.biopha.2021.112527_bib46","unstructured":"World Health Organization. WHO Tracking SARS-CoV-2 variants (Accessed 4 December 2021). Available from: https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/."},{"key":"10.1016\/j.biopha.2021.112527_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2021.07.002","article-title":"Trajectory of growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in Houston, Texas, January through May 2021, based on 12,476 genome sequences","author":"Olsen","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2122","article-title":"Angiotensin\u2010converting enzyme 2: the old door for new severe acute respiratory syndrome coronavirus 2 infection","volume":"30","author":"Tan","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.biopha.2021.112527_bib49","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard (Accessed 6 December 2021)."},{"issue":"14","key":"10.1016\/j.biopha.2021.112527_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.15585\/mmwr.mm7014e2","article-title":"Death Certificate\u2013Based ICD-10 diagnosis codes for COVID-19 Mortality Surveillance \u2014 United States, January\u2013December 2020","volume":"70","author":"Gundlapalli","year":"2021","journal-title":"MMWR Morb. Mortality Wkly Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.112527_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15585\/mmwr.mm7003e2","article-title":"Emergence of SARS-CoV-2 b. 1.1. 7 lineage\u2014United States, December 29, 2020\u2013January 12, 2021.","volume":"70","author":"Galloway","year":"2021","journal-title":"Morb. Mortality Wkly. Rep."},{"key":"10.1016\/j.biopha.2021.112527_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111352","article-title":"SARS-CoV-2: from the pathogenesis to potential anti-viral treatments","author":"Zarandi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112527_bib53","series-title":"Annales d\u2032endocrinologie","article-title":"Renin-Angiotensin-Aldosterone System and COVID-19 Infection","author":"Alexandre","year":"2020"},{"issue":"3","key":"10.1016\/j.biopha.2021.112527_bib54","first-page":"257","article-title":"Free SARS-CoV-2 spike protein S1 particles may play a role in the pathogenesis of COVID-19 infection","volume":"86","author":"Letarov","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2021.112527_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105996","article-title":"Severe respiratory SARS-CoV2 infection: does ACE2 receptor matter?","volume":"168","author":"Perrotta","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104260","article-title":"Genetic diversity and evolution of SARS-CoV-2","volume":"81","author":"Phan","year":"2020","journal-title":"Infect., Genet. Evol."},{"key":"10.1016\/j.biopha.2021.112527_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198154","article-title":"SARS-CoV-2 host tropism: an in silico analysis of the main cellular factors","volume":"289","author":"Rangel","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.biopha.2021.112527_bib58","article-title":"501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimabin vitro","author":"Liu","year":"2021","journal-title":"bioRxiv."},{"issue":"3","key":"10.1016\/j.biopha.2021.112527_bib59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41577-020-00493-9","article-title":"Endemic SARS-CoV-2 will maintain post-pandemic immunity","volume":"21","author":"Veldhoen","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.112527_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.05.010","article-title":"The global impact of the coronavirus pandemic","volume":"53","author":"Hiscott","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2021.112527_bib61","first-page":"1","article-title":"SARS\u2011CoV-2 RBD219-N1C1: a yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice","author":"Pollet","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biopha.2021.112527_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1344","article-title":"Suspend intellectual property rights for covid-19 vaccines","author":"Krishtel","year":"2021","journal-title":"Br. Med. J. Publ. Group"},{"key":"10.1016\/j.biopha.2021.112527_bib63","first-page":"1","article-title":"BNT162b2 mRNA COVID-19 vaccine: first approval","author":"Lamb","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib65","first-page":"1","article-title":"mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar","author":"Chemaitelly","year":"2021","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.biopha.2021.112527_bib66","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib67","article-title":"Vaccines for COVID-19: where do we stand in 2021?","author":"Sharma","year":"2021","journal-title":"Paediatr. Resp. Rev."},{"issue":"20","key":"10.1016\/j.biopha.2021.112527_bib68","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B. 1.351 Variant","volume":"384","author":"Shinde","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12529","article-title":"Vaccine\u2010induced immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41591-021-01316-7","article-title":"Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine","volume":"27","author":"Levine-Tiefenbrun","year":"2021","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112527_bib71","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib72","first-page":"1","article-title":"Structures of SARS-CoV-2 B. 1.351 neutralizing antibodies provide insights into cocktail design against concerning variants","author":"Du","year":"2021","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112527_bib73","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","article-title":"A comprehensive review of the global efforts on COVID-19 vaccine development","volume":"7","author":"Li","year":"2021","journal-title":"ACS Central Sci."},{"issue":"7830","key":"10.1016\/j.biopha.2021.112527_bib74","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib75","first-page":"1","article-title":"The way of SARS-CoV-2 vaccine development: success and challenges","volume":"6","author":"Dong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2021.112527_bib76","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/vaccines9111299","article-title":"COVID-19 Vaccine Boosters: the good, the bad, and the ugly","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2021.112527_bib77","first-page":"1","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","author":"Choi","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib78","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fphys.2020.571416","article-title":"Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?","volume":"11","author":"Bajaj","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2021.112527_bib79","first-page":"1","article-title":"Boosting immunity to COVID-19 vaccines","author":"Juno","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib80","unstructured":"Centers for Disease Control and Prevention, CDC Global COVID-19 Vaccinations (Accessed 4 December 2021). Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#global-vaccinations."},{"key":"10.1016\/j.biopha.2021.112527_bib81","first-page":"1616","article-title":"A Mix and Match Approach to COVID-19 Vaccinations: Does Nigeria Have a Choice?","author":"Al-Mustapha","year":"2021","journal-title":"Front. Public Health"},{"issue":"22","key":"10.1016\/j.biopha.2021.112527_bib82","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"22","key":"10.1016\/j.biopha.2021.112527_bib83","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112527_bib84","article-title":"COVID\u201019 vaccines mix\u2010and\u2010match: the concept, the efficacy and the doubts","author":"Rashedi","year":"2021","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112527_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23173-1","article-title":"Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice","volume":"12","author":"Spencer","year":"2021","journal-title":"Nat. Commun."},{"issue":"10295","key":"10.1016\/j.biopha.2021.112527_bib86","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(21)01420-3","article-title":"Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"398","author":"Borobia","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.biopha.2021.112527_bib87","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat. Med."},{"issue":"7885","key":"10.1016\/j.biopha.2021.112527_bib88","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/d41586-021-03074-5","article-title":"COVID antiviral pills: what scientists still want to know","volume":"599","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112527_bib89","article-title":"Covid-19: doctors will refuse to limit use of antiviral drug to unvaccinated patients, say ethicists","author":"Dyer","year":"2021","journal-title":"Br. Med. J. Publ. Group"},{"key":"10.1016\/j.biopha.2021.112527_bib90","doi-asserted-by":"crossref","unstructured":"Matrajt, L., et al., The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study. Medrxiv, 2021.","DOI":"10.1101\/2021.11.10.21266139"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:42:33Z","timestamp":1779964953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221013147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":90,"alternative-id":["S0753332221013147"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112527","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112527"}}